Back to search
FDAFDA · Food and drugs·Recall number D-0058-2021

Metformin HCL E/R 500 mg, 90 Tabs, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 72189-064-90

Published November 11, 2020 · Recall initiated: October 12, 2020

Summary

FDA records drug Class II recall D-0058-2021, published November 11, 2020 and initiated October 12, 2020. Recalling firm: Direct Rx; Status: Terminated; Reported quantity: 88 bottles; Lot: Lot: 04DE1902, 11DE1908 Exp. 06/30/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

What to do

Voluntary: Firm initiated · Letter

Get an email if METFORMIN HYDROCHLORIDE EXTENDED RELEASE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METFORMIN HYDROCHLORIDE EXTENDED RELEASE
Manufacturer
Direct Rx
Distributor
FL
Lot
Lot: 04DE1902, 11DE1908 Exp. 06/30/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metformin HCL E/R 500 mg, 90 Tabs, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 72189-064-90 recalled?

Yes. FDA published recall D-0058-2021 on November 11, 2020. Reported hazard: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METFORMIN HYDROCHLORIDE EXTENDED RELEASE.